#GUTImages from the paper by Gabriëls et al on

'Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease' via

bit.ly/3UfKhz9

#IBD #Vedo

#GUTImages from the #RecentAdvancesInClinicalPractice paper by Florian Rieder et al entitled

'Fibrosis in IBD: from pathogenesis to therapeutic targets' via bit.ly/4aLgTpO

Cleveland Clinic MD Pranab Mukherjee #Fibrosis #IBD

The BSG 2024 #HCC guidelines recommend 🔬🧬liver biopsy for HCC diagnosis if systemic therapy is considered! EASLnews European Society of Pathology (ESP) HASL my_UEG AASLD UK Liver Pathology Group Hans Popper Hepatopathology Society ILCA

#GUTAbstract by Hamada et al on the paper

'Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms: comparative cost-effectiveness of surveillance by age' via bit.ly/3Ukxsm5

Paper: bit.ly/3QlXxQj

#IPMN UTokyo | 東京大学

New #GUTPodcast live today by Kurtis Budden Hansbro Research

Apple: apple.co/3WnRI8R
Spotify: spoti.fi/3Un9Ih5
Web: bit.ly/49Zxq91

Paper: bit.ly/4cRc40e

Uni Newcastle Research HMRI - Hunter Medical Research Institute Sj Sijie Shen Dr Nádia Amorim @simonkeelyvia #COPD #Microbiome

Read the new BSG #GUTGuideline by Suddle et al entitled

'British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults' via bit.ly/3UudyX8

Dina Tiniakos #HCC

#GUTImage from the paper by Kong et al entitled

'Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis' via

bit.ly/4aSqPhE

#LiverTwitter #Fibrosis

I was delighted to help write this interesting paper on postprandial symptoms in #DGBI for Gut Journal with two giants of the field: Heidi Staudacher PhD AdvAPD and Prof. Nick Talley

gut.bmj.com/content/early/…

In Gut Journal, a study 'sought to evaluate the relationship between smoking, Lactobacillus and colorectal #cancer immune cell infiltration using Mendelian randomisation methods.'

#microbiota 👇

gut.bmj.com/content/early/…

More MR studies on drug effects are coming out. We cannot use genetic variants associated with drug intake behaviors as instrumental variables. Why? Please read our letter in Gut Journal.

gut.bmj.com/content/early/…

This is a critical point. Drug target MR investigations should use genetic variants in biologically-relevant gene regions that mimic the intervention of interest. Not genetic variants that predict drug prescription or drug usage.

Alexander Ford Gut Journal Prof. Nick Talley Thanks for leading this @alex_ford1239 - great to work with you & Prof. Nick Talley.

Why do patients with disorders of gut-brain interaction experience postprandial symptoms?

#MedTwitter #GITwitter #DGBI

gut.bmj.com/content/early/…

Researchers from Mass General Surgery Broad Institute and colleagues create a hypothesis of a sterile pancreas environment, in a Gut Journal study. doi.org/10.1136/gutjnl…

Postprandial symptoms related to #IBS by Heidi Staudacher PhD AdvAPD Prof. Nick Talley Alexander Ford

Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts | Gut gut.bmj.com/content/73/4/5…

#GUTImage from the #RecentAdvancesInBasicScience paper by du Pre et al entitled

'Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodies' via
bit.ly/4cQpUjo

#Gluten #Coeliac #CeliacDisease

#GUTLetter by Ovesen et al on the paper

'Predicting treatment response in ASUC: do we measure systemic severity, organ response or both?' via

bit.ly/4ayr9SG

Rune Wilkens @jakobseidelin #ASUC

Really glad to share our most recent work published in Gut Journal, describing how the TLR8 agonist Selgantolimod regulates Kupffer cell differentiation and impairs HBV entry into hepatocytes.
Barbara Testoni Fabien Zoulim
ipcureb🇪🇺 #HBV #Kupffer
gut.bmj.com/content/early/…

In this paper, Andrés Roca shows plasticity in the identity of kupffer cells when treated with a TLR8 agonist. They downwind KC specific gene expression, and start resembling more like monocytes. And then initiate crosstalk with hepatocytes to obstruct HBV entry.